Exploring Synergy in Combinations of Tumor-Derived Vaccines That Harbor 4-1BBL, OX40L, and GM-CSF
Recent studies have demonstrated that combination of modulatory immune strategies may potentiate tumor cell elimination. Most strategies rely on the use of monoclonal antibodies that can block cell surface receptors to overcome tumor-induced immunosuppression or acting as costimulatory ligands to bo...
Збережено в:
| Автори: | , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Frontiers Media S.A.
2017-09-01
|
| Серія: | Frontiers in Immunology |
| Предмети: | |
| Онлайн доступ: | http://journal.frontiersin.org/article/10.3389/fimmu.2017.01150/full |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|